🍪 Our Cookies

This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.

Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.

US LevFin Wrap — From double-Bs to LMEs, and everything in-between

Share

Market Wrap

US LevFin Wrap — From double-Bs to LMEs, and everything in-between

David Bell's avatar
Emily Fasold's avatar
Bill Weisbrod's avatar
  1. David Bell
  2. +Emily Fasold
  3. + 1 more
6 min read

There’s plenty to keep track of in the leveraged finance market — whether it’s the volume of more aggressive financings hitting the tape for a wider range of borrowers, or the swathe of liability management exercises coming for highly levered companies still struggling for market access.

Refinancing and repricing activity are still the main focus: as we highlighted in our latest LevFin Primary Review, it all comes down one thing: spread compression, as demand continues to outweigh supply.

MoneyGram, Medline and Solenis were among the sponsor-backed names taking advantage of demand to manage their balance sheets this week.

Read all our public content for free

We won't spam. You can unsubscribe at any time.

What are you waiting for?

Try it out
  • We're trusted by the top 10 Investment Banks